Breast cancer panel halves turnaround time: Wei Shen, Ph.D.
About this episode
Wei Shen, Ph.D., explains how Mayo Clinic Laboratories' new breast cancer panel provides rapid results to guide critical treatment decisions.
(00:32)
Could you provide our listeners with a little bit about yourself and your background?
(01:28)
Could you give us a brief overview of the new rapid hereditary breast cancer panel?
(03:42)
Can you describe a little bit of the rationale behind the design and how it differs from similar tests?
(05:03)
Can you tell us a little bit more about which patients should have this testing?
(06:00)
How are the results of the hereditary breast cancer panel used in patient care?
(08:14)
Is there anything else you would like to add about the panel?
Get every episode summarized
Each time Answers from the Lab publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Answers from the Lab
Unique Assays Advance Care of Complex Autoimmune Skin Conditions
Answers from the Lab
Digital Advances: What’s Next for Clinical Diagnostics?
Answers from the Lab
Preeclampsia Test Helps Extend Pregnancy to Improve Outcomes
Answers from the Lab
Breakthrough Test Enhances Peripheral Neuropathy Care and Research
Answers from the Lab